/PRNewswire/ In an eight-week study, Biostrap Labs, the research division of the progressive digital health company Biostrap, found that short-term effects.
VANCOUVER, British Columbia, Oct. 20, 2021 KetamineOne Capital Limited , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments,. | October 20, 2021
/PRNewswire/ A seven-week study conducted by Biostrap Labs finds quantitative improvement in chronic pain, range of motion and physiological biometrics with.
Biostrap is being utilized for a study conducted by the National Institute on Minority Health and Health Disparities to investigate the long-term sequelae of COVID-19 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.